ARCH Venture Partners, established in 1986, is a U.S.-based venture capital firm with a global scope. It specializes in investing in technology companies, with a primary focus on life sciences. ARCH invests conservatively in seed rounds to mitigate risk, and then leads or co-leads subsequent financing rounds until liquidity. The firm is known for its success in commercializing technologies from academic research institutions and national laboratories, often investing in companies co-founded by scientists and entrepreneurs. ARCH has raised over $3 billion across ten funds and has invested in over 150 companies, typically committing between $50,000 and $150 million per company. It seeks a seat on the Board of Directors and maintains a presence in underserved geographic markets. ARCH's investors include corporations, pension funds, endowment funds, financial institutions, and private investors.
5001 Plaza on the Lake Blvd., Suite 103 Austin, TX 78746
Jacob Bauer
Venture Partner
Reetika Bhardwaj Ph.D
Senior Associate
Luciana Borio
Venture Partner
Kristina Burow
Managing Director
Kaye Foster
Venture Partner
Sean Kendall
Principal
Jay Kocherlakota
Senior Associate
Steven Lazarus
Co-Founder and Managing Director
Mark McDonnell
Managing Director, Chief Financial and Chief Administrative Officer
Scott Minick
Venture Partner
Peter Mintun Ph.D
Associate
Ari Nowacek
Principal, Chicago
Corey Ritter
Principal
Paul Thurk
Managing Director Europe
George Scangos Ph.D
Venture Partner
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.